What was Advagene Biopharma Co., Ltd.’s price range in the past 12 months?
Advagene Biopharma Co., Ltd. lowest stock price was TWD 19.50 and its highest was TWD 35.97 in the past 12 months.
What is Advagene Biopharma Co., Ltd.’s market cap?
Advagene Biopharma Co., Ltd.’s market cap is TWD 1.44B.
When is Advagene Biopharma Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Advagene Biopharma Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Advagene Biopharma Co., Ltd. pay dividends?
Advagene Biopharma Co., Ltd. does not currently pay dividends.
What is Advagene Biopharma Co., Ltd.’s EPS estimate?
Advagene Biopharma Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Advagene Biopharma Co., Ltd. have?
Advagene Biopharma Co., Ltd. has 69,380,000 shares outstanding.
Which hedge fund is a major shareholder of Advagene Biopharma Co., Ltd.?
Currently, no hedge funds are holding shares in TW:6709
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Advagene Biopharma Co., Ltd.
Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to pioneering advancements in vaccine science and associated medical solutions. Its current development portfolio comprises a nasal spray vaccine for influenza, various allergy-specific vaccines, and an immunotherapy targeting COVID-19.